
Surgical goggles: Are we trading focus for more data?
Immersive goggles are emerging as a tool in surgical settings, offering potential enhancements to visualization and precision during complex procedures.
Unpaid AI work: How it limits care for your patients
Integrating AI tools into clinical practice raises complex questions about how doctors should be reimbursed for their use. Current payment models are ill-equipped for these novel technologies.
Air pollution: Why policies fail, and patients pay the price
Despite clear evidence linking air pollution to adverse health outcomes, effective implementation of protective policies remains a significant hurdle.
Rheumatology care: Is lower drug cost worth limited access?
A new CMS drug pricing rule could lead to unintended consequences for patients with rheumatic diseases, according to the American College of Rheumatology.
Dialysis costs: Medicare as primary payer could save $1 billion
The Medicare Secondary Payer Act modestly reduced federal dialysis spending, but only when private prices were less than 3.05 times Medicare rates.
Your white coat isn't the authority it once was. What is?
The traditional white coat, once a universal symbol of medical authority, has seen its prominence wane in clinical settings, replaced by scrubs and the simple passage of time.
Why vaccine skepticism thrives despite overwhelming data
Vaccine skepticism often thrives on narrative structures that bypass scientific evidence, creating powerful, emotionally resonant messages that challenge public health efforts.
ICD-11: What European GPs need to know about the new classification system
The ICD-11 system introduces significant changes to disease classification, impacting coding for conditions like hidradenitis suppurativa and neonatal encephalopathy.
Why patient-reported outcomes rarely make it onto drug labels
Despite their clinical relevance, patient-reported outcomes (PROs) face significant hurdles in gaining regulatory approval for inclusion on drug labels.